跳至主要内容
临床试验/ACTRN12607000145404
ACTRN12607000145404已完成未知

Trans Tasman Radiation Oncology Group (TROG) 04.02 - Prospective Study to Determine the Relationships Between Survival and International Federation of Gynecology and Obstetrics (FIGO) Stage, Tumour Volume and Corpus Invasion in relation to prognostic information in patients with Cervical Cancer

TROG Cancer Research0 个研究点目标入组 280 人开始时间: 2007年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Newly diagnosed, biopsy proven carcinoma of the uterine cervix.- Squamous cell, adenocarcinoma, adenosquamous or large cell carcinoma histology.- FIGO Stage Ib –IVa.- Maximum clinical tumour diameter recorded.- MRI done within 30 days prior to registration.- Intention to treat radically- Treatment not yet started.- Written informed consent.- Available for follow-up.

排除标准

  • Lymphoma, small cell carcinoma and melanoma histology.- Previous hysterectomy- Pregnancy- Prior malignancy excluding basal cell carcinoma (BCC) of the skin.

研究者

相似试验